![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 223/16 | |
A61K 31/55 | |||
A61P 3/04 |
(11) | Number of the document | 2332921 |
(13) | Kind of document | T |
(96) | European patent application number | 10010301.9 |
Date of filing the European patent application | 2004-06-16 | |
(97) | Date of publication of the European application | 2011-06-15 |
(45) | Date of publication and mention of the grant of the patent | 2016-03-02 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
479280 P | 2003-06-17 | US | |
512967 P | 2003-10-21 | US |
(72) |
Throop, Beverly W., US
Gilson, Charles A., III., US
Aytes, Shelley, US
Estrade, Scott A., US
Sengupta, Dipanjan, US
Smith, Brian, US
Rey, Max, CH
Weigl, Ulrich, DE
|
(73) |
Arena Pharmaceuticals, Inc.,
6154 Nancy Ridge Drive, San Diego, CA 92121,
US
|
(54) | 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride |
8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride |